We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-3.41%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$67.1B
AUM Growth
-$1.4B
Cap. Flow
+$2.19B
Cap. Flow %
3.26%
Top 10 Hldgs %
22.03%
Holding
3,122
New
29
Increased
2,768
Reduced
217
Closed
40

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$146M
2
AAPL icon
Apple
AAPL
+$75.7M
3
TSLA icon
Tesla
TSLA
+$70.4M
4
AMZN icon
Amazon
AMZN
+$65M
5
PG icon
Procter & Gamble
PG
+$55.9M

Sector Composition

Rank Sector Weight
1 Technology 22.83%
2 Healthcare 14.42%
3 Financials 13.62%
4 Consumer Discretionary 11.36%
5 Industrials 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KRUS icon
2576
Kura Sushi USA
KRUS
$593M
$418K ﹤0.01%
5,681
+477
+9% +$36.7K
BSRR icon
2577
Sierra Bancorp
BSRR
$525M
$417K ﹤0.01%
21,111
+1,210
+6% +$25.9K
PNC.PRP
2578
DELISTED
THE PNC FINANCIAL SERVICES GROUP, INC.
PNC.PRP
$416K ﹤0.01%
16,375
IWS icon
2579
iShares Russell Mid-Cap Value ETF
IWS
$15.9B
$413K ﹤0.01%
+4,302
New +$460K
FRST icon
2580
Primis Financial Corp
FRST
$404M
$412K ﹤0.01%
33,937
+2,127
+7% +$28.1K
GWH icon
2581
ESS Tech
GWH
$18.9M
$412K ﹤0.01%
6,710
+439
+7% +$26K
KOD icon
2582
Kodiak Sciences
KOD
$2.84B
$412K ﹤0.01%
53,286
+1,842
+4% +$17.9K
MVST icon
2583
Microvast
MVST
$302M
$412K ﹤0.01%
227,353
+1,209
+0.5% +$2.89K
OCUL icon
2584
Ocular Therapeutix
OCUL
$2.02B
$412K ﹤0.01%
99,332
+8,837
+10% +$44.5K
ALBO
2585
DELISTED
Albireo Pharma Inc
ALBO
$412K ﹤0.01%
21,297
+1,424
+7% +$29.4K
BRT
2586
BRT Apartments
BRT
$271M
$411K ﹤0.01%
20,217
+1,042
+5% +$23.8K
FEAM icon
2587
5E Advanced Materials
FEAM
$62.3M
$411K ﹤0.01%
1,757
+162
+10% +$57.4K
FULC icon
2588
Fulcrum Therapeutics
FULC
$297M
$410K ﹤0.01%
50,727
+3,200
+7% +$22.9K
KODK icon
2589
Kodak
KODK
$983M
$410K ﹤0.01%
89,338
+4,879
+6% +$26.6K
EIGR
2590
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$409K ﹤0.01%
1,812
+111
+7% +$27.3K
UFI icon
2591
UNIFI
UFI
$134M
$407K ﹤0.01%
42,796
+1,017
+2% +$12.7K
JMSB icon
2592
John Marshall Bancorp
JMSB
$329M
$406K ﹤0.01%
16,519
+924
+6% +$23.4K
AURA icon
2593
Aura Biosciences
AURA
$826M
$405K ﹤0.01%
22,339
+1,626
+8% +$24.6K
BIRD icon
2594
Smartbird Inc
BIRD
$22.3M
$405K ﹤0.01%
6,662
+413
+7% +$36.5K
PSTL
2595
Postal Realty Trust
PSTL
$699M
$405K ﹤0.01%
27,589
+1,877
+7% +$29.2K
ARCC icon
2596
Ares Capital
ARCC
$14.4B
$404K ﹤0.01%
23,953
+810
+3% +$15.7K
FNLC icon
2597
First Bancorp
FNLC
$399M
$404K ﹤0.01%
14,670
+705
+5% +$20.9K
VXRT
2598
DELISTED
Vaxart
VXRT
$401K ﹤0.01%
183,816
+6,653
+4% +$22.9K
TPB icon
2599
Turning Point Brands
TPB
$1.74B
$400K ﹤0.01%
18,826
+1,286
+7% +$31.9K
RILYK
2600
DELISTED
BRC Group Holdings 5.50% Senior Notes Due 2026
RILYK
$399K ﹤0.01%
16,675

Similar funds

RhumbLine Advisers's Q3 2022 Portfolio in Review

As of Q3 2022, RhumbLine Advisers held 3,122 positions worth $67.1B, down 2% from $68.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

RhumbLine Advisers deployed $2.19B of net new capital in Q3 2022, opening 29 new positions and adding to 2,768 existing holdings. Its largest new stake was Enhabit: 136,327 shares worth $1.91M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $21.1M trimmed.

  • RhumbLine Advisers's largest Q3 2022 buy was Enhabit: 136,327 shares worth $1.91M.
  • RhumbLine Advisers added most to Microsoft in Q3 2022, an estimated $146M increase.
  • RhumbLine Advisers's biggest Q3 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $21.1M.
  • RhumbLine Advisers fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $27.2M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $67.1B portfolio in Q3 2022.
  • RhumbLine Advisers opened 29 new positions and closed 40 in Q3 2022.
  • RhumbLine Advisers's portfolio value fell 2% quarter-over-quarter to $67.1B.

Based on RhumbLine Advisers's 13F filing for Q3 2022, filed 10 Nov 2022.